CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company
BioRestorative Therapies, Inc.
Sign in to watch- Ticker
- BRTX
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 301341024
- Phone
- (631) 760-8100
- Business address
- 40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
- Former names
- Stem Cell Assurance, Inc.
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K/A Event Executive or director change
- NT 10-K Other NT 10-K
- 10-Q Report Quarterly Report
- 3 Insider Initial Statement of Ownership
- 4 Grant or award VP of Research and Development acquired 586,958,987 shares (grant or award)
- 4 Grant or award President, CEO, COB acquired 586,958,987 shares (grant or award)
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Auditor change
- 4 Other acquisition President, CEO, COB acquired 18,661,666 shares (other)
- 4 Other acquisition VP of Research and Development acquired 8,375,671 shares (other)
- 8-K Event Bankruptcy · New debt or obligation · Unregistered share sale · Executive or director change · Bylaws or fiscal year change
- 8-K Event Bankruptcy
Page 16 of 38 · 755 filings